|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Genpact Limited is engaged in providing digitally powered business process management and services. The Company's segments include Business process outsourcing and Information technology services. The Company offers various vertical activities, which include banking and financial services; capital markets; insurance; consumer goods and retail; life sciences and healthcare; infrastructure, manufacturing and services, and High Tech. In addition to these vertical activities, it also offers analytics and research, collections and customer services, consulting and transformation services, core industry operations services, enterprise application services, finance and accounting (F&A) services, information technology (IT) infrastructure management services, and supply chain and procurement services. The Company also offers data engineering and data-led digital transformation services.
- James Madden NEC (59)
- N.V. Tyagarajan CEO
- Michael Weiner CFO (49)
- Piyush Mehta CHO (52)
- Heather White SVP (48)
- Patrick Cogny SVP (54)
- Edward Fitzpatrick SVP (54)
- Balkrishan Kalra SVP (51)
- Darren Saumur SVP (53)
- Kathryn Stein SVP (44)
- Ajay Agrawal IND (51)
- Stacey Cartwright IND (57)
- Laura Conigliaro IND (75)
- Tamara Franklin IND (54)
- Carol Lindstrom IND (67)
- CeCelia Morken IND (63)
- Mark Nunnelly IND (62)
- Brian Stevens IND (57)
- Mark Verdi IND (54)
- Canon's Court, 22 Victoria Street, HAMILTON, HM 12
- +1 4412952244
- KPMG Assurance Services Ltda.
Upcoming Events for G
Q2 2022 Genpact Ltd Earnings Release
Q3 2022 Genpact Ltd Earnings Release
As of Today at 13:09 UTC, shares in Genpact are trading at $41.62. This share price information is delayed by 15 minutes.
Shares in Genpact last closed at $41.62 and the price had moved by -7.41% over the past 365 days. In terms of relative price strength the Genpact share price has outperformed the S&P500 Index by +6.45% over the past year.
The overall consensus recommendation for Genpact is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Genpact dividend yield is 1.08% based on the trailing twelve month period.
Last year, Genpact paid a total dividend of $0.45, and it currently has a trailing dividend yield of 1.08%. We do not have any data on when Genpact is to next pay dividends.
We do not have data on when Genpact is to next pay dividends. The historic dividend yield on Genpact shares is currently 1.08%.
To buy shares in Genpact you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $41.62, shares in Genpact had a market capitalisation of $7.71bn.
Here are the trading details for Genpact:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: G
Based on an overall assessment of its quality, value and momentum Genpact is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Genpact is $51.60. That is 23.98% above the last closing price of $41.62.
Analysts covering Genpact currently have a consensus Earnings Per Share (EPS) forecast of $2.69 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genpact. Over the past six months, its share price has outperformed the S&P500 Index by +5.61%.
As of the last closing price of $41.62, shares in Genpact were trading -11.22% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Genpact PE ratio based on its reported earnings over the past 12 months is 14.58. The shares last closed at $41.62.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Genpact's management team is headed by:
- James Madden - NEC
- N.V. Tyagarajan - CEO
- Michael Weiner - CFO
- Piyush Mehta - CHO
- Heather White - SVP
- Patrick Cogny - SVP
- Edward Fitzpatrick - SVP
- Balkrishan Kalra - SVP
- Darren Saumur - SVP
- Kathryn Stein - SVP
- Ajay Agrawal - IND
- Stacey Cartwright - IND
- Laura Conigliaro - IND
- Tamara Franklin - IND
- Carol Lindstrom - IND
- CeCelia Morken - IND
- Mark Nunnelly - IND
- Brian Stevens - IND
- Mark Verdi - IND